Polidexide Sulfate

CHEMBL2107943 Phase 4 Disetujui Small molecule

Half-Life

—

Bioavailability

—

Protein Binding

—

Molecular Weight

— g/mol

LogP

—

Phase

4

Polidexide sulfate is a polymeric ion-exchange resin that binds bile acids in the gastrointestinal tract, interrupting their enterohepatic circulation and promoting their fecal excretion, thereby reducing cholesterol levels. It was investigated as an alternative bile acid sequestrant for the treatment of hypercholesterolemia.

Pharmacokinetics (PK)

Pharmacodynamics (PD)

HBD / HBA

- / -

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Pertanyaan yang Sering Diajukan

Polidexide sulfate is a polymeric ion-exchange resin that binds bile acids in the gastrointestinal tract, interrupting their enterohepatic circulation and promoting their fecal excretion, thereby reducing cholesterol levels. It was investigated as an alternative bile acid sequestrant for the treatment of hypercholesterolemia.

Yes, Polidexide Sulfate is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

ChEMBL — European Bioinformatics Institute (EBI). CHEMBL2107943. Open-access bioactivity database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-02-27.

PillFYI

Mencari informasi yang ramah bagi pasien?

Polidexide Sulfate di PillFYI

Data Cepat

Tautan Eksternal

ChEMBL CHEMBL2107943

Cite

BibTeX, APA, MLA, Chicago, IEEE, Harvard

Penyangkalan Medis

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.